Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-002957 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 16, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
211,500
Total Value
$0.00
P&L
+inf% (+$617,580.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Regulatory Officer | Common Stock | โ | Jan 16, 2026 | Grant/Award | 84,600 | $0.00 | $0.00 | 92,303 | Direct | โ | View Details | |
Chief Regulatory Officer | Employee Stock Option (right to buy) | Derivative | Jan 16, 2026 | Grant/Award | 126,900 | $0.00 | $0.00 | 126,900 | Direct | โ | View Details |